Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting.


Coram CVS Specialty Infusion Services, 555 17th St. Suite 1500, Denver, CO, 80202, USA. [Email]


Infliximab is a chimeric anti-tumor necrosis factor alpha (TNF-α) monoclonal antibody that ameliorates inflammation when it binds to and neutralizes TNF-α. It is often used in patients with Crohn's disease and ulcerative colitis to reduce the severity of disease symptoms and induce disease remission. Infusions are generally administered in the hospital setting due to concerns over patient safety, and limited data exist regarding the incidence and management of infusion reactions (IRs) in an alternate care setting without direct physician oversight.


Home healthcare,Inflammatory bowel disease,Infliximab,Infusion reaction,